Skip to Content

WPI 2232 (Tamoxifen Citrate 10 mg)

Pill with imprint WPI 2232 is White, Round and has been identified as Tamoxifen Citrate 10 mg. It is supplied by Watson Pharmaceuticals, Inc..

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, male; breast cancer, metastatic; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2232

Tamoxifen citrate 10 mg WPI 2232
Tamoxifen citrate 10 mg WPI 2232
Tamoxifen citrate 10 mg WPI 2232
Tamoxifen citrate 10 mg WPI 2232

Tamoxifen Citrate

Imprint:
WPI 2232
Strength:
10 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals, Inc.
National Drug Code (NDC):
00591-2232

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide